Clinical Evidence
The Biochemical Baseline: Proving the Receptor Mechanism
Published in Biochemical and Biophysical Research Communications (BBRC), this foundational study establishes the biophysical reality of the rs5522 mineralocorticoid receptor variant. By mapping the receptor’s intense binding affinity, this paper provides the definitive laboratory proof backing the "cortisol steal"—demonstrating exactly how an overactive MR receptor drives cellular-level capture of corticosteroids that directly ignites tissue inflammation and systemic dysregulation.
Spironolactone for ME/CFS in a Patient Homozygous for rs5522 (I180V): A Case Report
This case report documents the successful, long-term reversal of 28-year treatment-resistant ME/CFS, offering a detailed, clinical roadmap for overcoming this condition. It presents a comprehensive, evidence-based argument that chronic inflammation is the core mechanism driving nearly all modern chronic illnesses.
Clinical Evidence for MR Antagonists
This review pulls together decades of existing, peer-reviewed literature to map out the safety and profound effectiveness of mineralocorticoid receptor (MR) antagonists across a wide variety of conditions. By synthesizing global clinical data, this research demonstrates that targeted MR blockade is not a niche treatment, but a foundational, safe intervention capable of arresting the systemic inflammation and fluid dysregulation that underpins modern chronic disease.
Spironolactone reduces COVID-19 risk: real-time meta-analysis of 12 studies
A real-time meta-analysis of 12global studies, covering over 20,000 patients, indicates that spironolactone significantly reduces the risk of severe COVID-19 progression and mortality. By blocking the hyper-inflammatory RAAS cascade and endothelial fluid leaks, this data supports the use of mineralocorticoid receptor (MR) antagonists to mitigate tissue-level vascular stress associated with both acute infection and long COVID. For more details, visit c19early.org.
It's Fluid! Not Fat. Rethinking Obesity
This groundbreaking framework challenges the conventional, multi-billion-dollar calorie narrative by redefining obesity at its root. Instead of treating weight management as a simple struggle against fat accumulation, this research proves that the core issue is often chronic, tissue-level fluid retention driven by upstream mineralocorticoid receptor overdrive and capillary leaks. By treating the underlying cellular inflammation rather than counting calories, this article exposes why mainstream treatments fail and offers a roadmap to successful weight management.
Logic Chain: If this is true, the system is blind
This framework pieces together the absolute logical sequence proving that global medicine is a rigged, profit-driven failure. By documenting mainstream peer-reviewed data, including the Aldo-DHF data and the JUPITER trial, this framework demonstrates how a genetic "stuck switch" (rs5522) fuels a cellular "cortisol steal" that ignites vascular leaks and chronic inflammation.
Media
The Medium Series: Mapping rs5522 and Systemic Blindness
Below is a collection of articles that break down exactly how the rs5522 genetic variant causes disease and why mainstream medicine completely missed the underlying pattern.
